Trials / Completed
CompletedNCT01788319
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | lasertrabeculoplasty |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-12-01
- Completion
- 2015-06-01
- First posted
- 2013-02-11
- Last updated
- 2015-06-23
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01788319. Inclusion in this directory is not an endorsement.